Literature DB >> 17126418

Development of AAV serotype-specific ELISAs using novel monoclonal antibodies.

Dirk Kuck1, Andrea Kern, Jürgen A Kleinschmidt.   

Abstract

Adeno-associated viruses (AAV) have been developed and evaluated as recombinant vectors for gene therapy. More recently, due to the advantages they offer for gene transfer, several AAV serotypes have gained increasing interest. However, monoclonal antibodies for the characterization and quantitation of vectors derived from different serotypes are at present not available. Serotype-specific monoclonal antibodies (mAbs) against the capsids of the serotypes 1/6, 4 and 5 are described. These antibodies, designated as ADK1a and b, ADK4 or ADK5a and b, reacted specifically with the indicated serotype capsids in cell lysates. ADK 1a and b cross-reacted with its highly related AAV6 serotype, but not with the other serotypes tested. The new antibodies recognized exclusively assembled capsids and neither free nor denatured capsid proteins as shown by fractionation experiments. In immunofluorescence experiments, the mAbs stained only distinct intranuclear foci in cells expressing the capsid protein. The development of capture ELISAs for quantitation of AAV1 and 6, AAV4 or AAV5 capsids illustrates that these novel monoclonal antibodies provide valuable tools for characterization of vector stocks.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126418     DOI: 10.1016/j.jviromet.2006.10.005

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  35 in total

1.  Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5.

Authors:  Carole E Harbison; Wendy S Weichert; Brittney L Gurda; John A Chiorini; Mavis Agbandje-McKenna; Colin R Parrish
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

2.  Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates.

Authors:  Knut Stieger; Josef Schroeder; Nathalie Provost; Alexandra Mendes-Madeira; Brahim Belbellaa; Guylène Le Meur; Michel Weber; Jack-Yves Deschamps; Birgit Lorenz; Philippe Moullier; Fabienne Rolling
Journal:  Mol Ther       Date:  2008-12-23       Impact factor: 11.454

3.  Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.

Authors:  Brittney L Gurda; Christina Raupp; Ruth Popa-Wagner; Matthias Naumer; Norman H Olson; Robert Ng; Robert McKenna; Timothy S Baker; Jürgen A Kleinschmidt; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

4.  Capsid antibodies to different adeno-associated virus serotypes bind common regions.

Authors:  Brittney L Gurda; Michael A DiMattia; Edward B Miller; Antonette Bennett; Robert McKenna; Wendy S Weichert; Christian D Nelson; Wei-jun Chen; Nicholas Muzyczka; Norman H Olson; Robert S Sinkovits; John A Chiorini; Sergei Zolotutkhin; Olga G Kozyreva; R Jude Samulski; Timothy S Baker; Colin R Parrish; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

5.  OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy.

Authors:  Mario Mietzsch; Sabrina Grasse; Catherine Zurawski; Stefan Weger; Antonette Bennett; Mavis Agbandje-McKenna; Nicholas Muzyczka; Sergei Zolotukhin; Regine Heilbronn
Journal:  Hum Gene Ther       Date:  2014-01-23       Impact factor: 5.695

6.  A viral assembly factor promotes AAV2 capsid formation in the nucleolus.

Authors:  Florian Sonntag; Kristin Schmidt; Jürgen A Kleinschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

7.  Quantification of AAV particle titers by infrared fluorescence scanning of coomassie-stained sodium dodecyl sulfate-polyacrylamide gels.

Authors:  Erik Kohlbrenner; Els Henckaerts; Kleopatra Rapti; Ronald E Gordon; R Michael Linden; Roger J Hajjar; Thomas Weber
Journal:  Hum Gene Ther Methods       Date:  2012-07-20       Impact factor: 2.396

8.  Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material.

Authors:  Eduard Ayuso; Véronique Blouin; Martin Lock; Susan McGorray; Xavier Leon; Mauricio R Alvira; Alberto Auricchio; Stephanie Bucher; Abdelwahed Chtarto; K Reed Clark; Christophe Darmon; Monica Doria; Will Fountain; Guangping Gao; Kai Gao; Mauro Giacca; Juergen Kleinschmidt; Barbara Leuchs; Catherine Melas; Hiroaki Mizukami; Marcus Müller; Yvet Noordman; Olivier Bockstael; Keiya Ozawa; Catherine Pythoud; Marina Sumaroka; Richard Surosky; Liliane Tenenbaum; Inge van der Linden; Brigitte Weins; J Fraser Wright; Xinhua Zhang; Lorena Zentilin; Fatima Bosch; Richard O Snyder; Philippe Moullier
Journal:  Hum Gene Ther       Date:  2014-11       Impact factor: 5.695

9.  Adeno-associated Virus (AAV) Assembly-Activating Protein Is Not an Essential Requirement for Capsid Assembly of AAV Serotypes 4, 5, and 11.

Authors:  Lauriel F Earley; John M Powers; Kei Adachi; Joshua T Baumgart; Nancy L Meyer; Qing Xie; Michael S Chapman; Hiroyuki Nakai
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

10.  Filling Adeno-Associated Virus Capsids: Estimating Success by Cryo-Electron Microscopy.

Authors:  Suriyasri Subramanian; Anna C Maurer; Carol M Bator; Alexander M Makhov; James F Conway; Kevin B Turner; James H Marden; Luk H Vandenberghe; Susan L Hafenstein
Journal:  Hum Gene Ther       Date:  2019-11-14       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.